SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " GLP-1s " 89 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often
Scant data about serious adverse effects makes it harder to answer scientific and legal questions about how often the drugs might cause serious harm like blindness or pancreatitis.
This Week in Science: Mosquito Magnets, Bonus Benefits of GLP-1s, And More
Our weekly science news roundup.
Bonus Features – September 6, 2026 – 59% of clinicians say TikTok is the top source of misinformation about GLP-1s, AMA names leader for new Center for Digital Health and AI, plus 32 more stories
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hi
Health spending at state’s top insurer surged 12%, led by GLP-1s
Healthcare spending growth at the state’s largest commercial insurer surged by nearly 12% in fiscal 2025, according to a new study that offers a jarring account of healthcare affordability wo…
Middle-aged adults taking GLP-1s for obesity can save over $192K on lifetime medical costs, higher if they don’t have college degrees, new study finds
The National Bureau of Economic Research paper's lead author hopes putting a dollar value on the benefits of GLP-1s will lead to better access
FDA has finalized its guidance on apps related to drugs
In this edition of STAT Health Tech: FDA's guidance on prescription drug use-related software, and telehealth pushing GLP-1s for addiction.
Interra Health Adds GLP-1 Bridge Program Support
Interra Health is helping Medicare patients access $50-per-month GLP-1s through the new Bridge program.
Scoop: Weight management company Wondr on the block
Both employer health costs and demand for GLP-1s are rising.
The Weight-Loss Price Wars Are Breaking Big Pharma’s Business Model
Prices for GLP-1s are falling fast, forcing companies to adapt.
An administrative gap delays access to new pancreatic cancer treatment
A new wave of illegal fruity vapes, more and more kids on GLP-1s, and other health news from Morning Rounds
The Vogue Business Spring/Summer 2027 Size Inclusivity Report
Amid accelerating access to GLP-1s, conservative undercurrents and a few glimmers of hope, curve representation on the runway remains low at just 2.5%.
Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China
Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping changes to vaccine policy.
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.
Together, GLP-1s And GenAI Can Solve Healthcare’s Affordability Crisis
Two innovations offer a new path to healthcare affordability: GLP-1 medications and generative AI. Here's how to two could radically improve medicine and lower costs.
Telehealth Booms As Demand For GLP-1s Surges and Questions Mount About Safety, Oversight
By Lauren Sausser and Maia Rosenfeld and KFF Health News HealthDay ReportersWEDNESDAY, JUNE 3, 2026 (HealthDay News) — Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she ...
Some people don’t lose weight with GLP-1s. Evidence is building that the drugs are helping anyway
The majority of people who start taking GLP-1 medicines with the hope of losing weight, the drugs can quiet cravings and help them shed stubborn pounds. But research is also continuing to reveal GLP-1 medicines’ benefits independent of weight loss — even if people gain weight.
LIFE-HEALTH-GLP-1S-ALCOHOL-FILEPIC-DMT
A Philadelphia Veterans Affairs doctor is leading a national trial testing whether GLP-1 drugs could help patients with alcohol use disorder.
GLP-1s are latest wedding trend that has serious implications
Doctors worry the drugs are becoming a wedding fad as online prescribing makes them easier to obtain.
In earnings call, Hims CEO addresses scrutiny of GLP-1 compounding
In earnings call, Hims & Hers CEO Andrew Dudum addressed the increased scrutiny on compounded GLP-1s and its impact on the business’s bottom line.
Penn researchers use AI to surface unreported GLP-1 side effects in Reddit posts
Could mining Reddit with AI help spot drug side effects earlier? A new Penn study suggests it might. Using large language models to map patient posts to standardized medical terms, researchers analyzed more than 400,000 Reddit posts about GLP-1s and found both known side effects and possibly underrecognized symptoms, like menstrual changes. The team says the approach could eventually help generate early safety signals for other drugs and wellness trends discussed online.
Why some companies may not be offering coverage for GLP-1 weight loss drugs
Some companies have said they are no longer offering health insurance coverage for GLP-1s for weight loss. Experts say this may be a "business decision."
There’s a Limit to How Much GLP-1s Can Do, According to a New Study
New research suggests the lifestyle perks may be overblown.
Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify
Medicare launched a pilot program that could streamline the process to get GLP-1s, with some seniors paying just $50 a month. But many people with the most serious illnesses won't get that discount.
Thanks to GLP-1s, Obesity Experts Are Trying to Understand ‘Food Noise’
Before the rise of GLP-1s, obesity experts didn’t study the internal buzz that compels people to eat. Now that food noise is being switched off, they want to understand it.
Can California help lower the cost of GLP-1s? Here’s what lawmakers are proposing
An LA-area Democrat wants California to partner with drug manufacturers to make weight loss drugs cheaper — drawing on her own experience paying out of pocket.
Medicare will soon offer some older Oregonians weight loss drugs for $50 a month. Here’s how it works.
Medicare has long excluded coverage of GLP-1s prescribed solely for weight loss.
Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health
Dr. Mehmet Oz backs GLP-1 weight loss medication, but stresses that diet and exercise remain essential, calling obesity the top driver of healthcare costs.
People are battling 'ghost fat' after losing weight on GLP-1s
Sometimes, seeing isn't believing.
GLP-1s may weaken the pelvic floor, impacting women's health –– and their sex lives
GLP-1 side effects like constipation and muscle mass loss can lead to uncomfortable pelvic floor symptoms like bladder leakage and painful sex.
Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device giant Dexcom.
Oura Ring Is Rolling Out New Health-Tracking Features: When to Unlock Them
Along with the launch of the Oura Ring 5, there will be new health features focusing on blood pressure, nighttime breathing, GLP-1s and more.
SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss
SheMed’s study of more than 8,000 women found improvements in weight, blood sugar, and cholesterol. Its founders believe that’s just the start of what GLP-1 research could uncover.
GLP-1s Like Ozempic, Mounjaro May Lower Fracture Risk in Type 2 Diabetes
A new study has found that GLP-1 medications, like Ozempic and Mounjaro, may help reduce the risk of fragility-related fractures in people with type 2 diabetes.
Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets
Watch this discussion on how GLP-1 drugs for obesity are changing the shape of U.S. healthcare. From direct-to-consumer portals to pharmacy deals, how these drugs reach patients is changing—and leading to debates over pricing and coverage. Learn how your company can be both patient-forward while also maximizing revenue in this unique environment.
2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA
Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.
Study suggests GLP-1 drugs have mental health perks
The study doesn’t prove causality or determine why GLP-1s could be a boon to people with mental illnesses.
‘Enough’ with blame and shame: The science behind obesity and GLP-1s
In a new book, Yale endocrinologist Ania Jastreboff teams up with Oprah Winfrey to transform how we think about health, weight, and obesity.
These people lost their sense of taste. Are GLP-1s to blame?
GLP-1s mute sugar in our bodies. That's impacting our taste buds.
Health insurance costs are projected to rise by most in more than 20 years
The 2027 projection would mark the fifth consecutive year of elevated health benefit cost growth after a decade of more moderate annual increases. It would also be the sharpest increase during the five-year period, up from a projected 6.7%…
GLP-1s may help –– not harm –– male fertility
Not only are GLP-1 medications likely not harmful to male fertility, but they may help improve testosterone levels, sperm health and production, study says.
Real-World Weight Journeys: Exploring Health Experiences to Improve Care
(Feature Impact) A number on a scale tells only part of the story. Living well is also about having energy, feeling your best and enjoying a good quality of life. Yet each person’s path is different, and lifestyle changes, medicines and other approaches to managing weight can affect health in different ways. TNCMS.AdManager.render({region: 'fixed-big-ad-top-asset', slot: 1, fold: "above"}); No two weight-management journeys look the same. Some people are taking their first steps toward healthier habits. Others are balancing health conditions, caring for family members, coping with stress or exploring new treatment options. Along the way, they may find support that helps them succeed or encounter obstacles that make progress more difficult.These stories provide valuable insights into what it takes to improve health in everyday life.That’s the idea behind the American Heart Association’s Healthy Living BEYOND Weight Study. By learning directly from adults across the country, researchers aim to better understand the challenges, motivations and factors that shape weight and health outcomes over time. The goal is to generate insights that can help improve support, inform care and empower more people to live healthier lives.What Factors Influence WeightNearly 1 in 3 U.S. adults are overweight and 2 in 5 are obese, according to the National Institutes of Health. Weight is shaped by many factors, including:Genetics and hormonesAccess to healthy food, safe places to exercise and healthcareChronic stress and mental healthMedications and metabolismCommunity conditions, as where you live can influence your ability to live a healthy lifeHow Joining a Study Can Make a Difference Led by the American Heart Association, the Healthy Living BEYOND Weight Study is open to U.S. adults with a BMI of 25 or higher, including those who have tried lifestyle changes, weight-management medicines or weight-loss surgery. By sharing information about their health and daily lives, participants can help researchers better understand how to improve care.Interest in newer weight-loss medicines, such as GLP-1s, has grown rapidly. While these treatments are helping many people, researchers are still learning about their long-term effects and how they fit into everyday life. People who currently use or previously used a GLP-1 may be eligible to participate and help generate insights that could improve care for others.Reasons to Join This StudyBy joining this study, participants can help researchers better understand the long-term impact of treatments, identify what helps people succeed and uncover the challenges they face along the way. The information they share can help fill important gaps in research, shape better and more compassionate care and guide future health recommendations.According to the Pew Research Center, 31% of U.S. adults report they’re online “almost constantly.” The study is conducted entirely online, making participation convenient and easy. It can be completed from home on a schedule that works best for each participant.Consider these reasons to participate:Your story matters. By participating, you may help build knowledge that can improve care, guide health recommendations and help people live healthier lives.It’s easy. The study is conducted entirely online, making it simple to join and stay involved at your own pace.It’s safe and respectful. All data is collected with your informed consent, protected by privacy safeguards and handled according to rigorous ethical and scientific standards.You won’t be alone. Millions of people are navigating weight and health challenges. By sharing your journey, you can help researchers better understand what works, what support is needed and how to shape better and more compassionate care for others.Learn more and consider signing up at Heart.org/GoBeyond.Photo courtesy of Shutterstock
Top Health Trends of 2026: GLP-1 Expansion, AI Wearables, More
Which health trends will be making the biggest waves in 2026? Gretel Schueller, managing editor of health at U.S. News and World Report, joins TODAY to share an exclusive look at their list of the top emerging health trends, including an expansion of GLP-1s for more health conditions, the integration of AI into wearable technology and more.
Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says
Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.
Shaquille O'Neal says he's taking GLP-1s. What it says about body image.
Shaquille O’Neal is the latest among a growing number of celebrities to disclose their usage of GLP-1 medications. What does it mean for body image?
These 10 Medications May Raise Your Risk of Heat-Related Illness
As summer temperatures climb, so do the risks of heat-related illnesses, particularly for those who take certain medications, such as GLP-1s, diuretics, antidepressants, and beta-blockers. Here's what you need to know to stay safe.
More people now use GLP-1s for weight loss than for other health conditions, research finds
Medicare’s mum on GLP-1s, and Massachusetts sues United
We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.
Which vaccines will curb the Ebola outbreak? WHO debates
The growing Ebola outbreak, the unknowns of microdosing GLP-1s, and more health news from Morning Rounds
From ‘Ozempic breath’ to hair loss: sorting the science from the hype about weight loss jabs
Do you gain weight once you stop using them? Do they make your face saggy? Can they improve your mental health? Experts explain whether 13 common beliefs about GLP-1s are true or false
Here’s What the World Health Organization Had to Say About GLP-1s in its First-Ever Guideline on the Drugs
The health agency supports the long-term use of the medications in combination with a healthy diet and exercise, and calls for equitable access to the drugs
GLP-1s 101: What the science says about weight loss, side effects, safety
We asked Stanford Medicine experts to break down everything you need to know about the drugs known as GLP-1s, semaglutide, Ozempic, Wegovy, Zepbound and many more.
US Workers’ Health Insurance Costs Set to Rise, Survey Finds
Employers say higher prices are forcing them to raise premiums. Some will also stop covering GLP-1s.
Driven by GLP-1s, prescription drug spending explodes at major health insurers
Some insurers have spent more on drugs in nine months this year than they did in all of 2024. Cost of weight loss drugs a major factor, STAT analysis finds.
GLP-1s Show Benefit For Kids With Type 2 Diabetes
By Ernie Mundell HealthDay ReporterFRIDAY, Oct 2, 2026 (HealthDay News) — A real-world study finds GLP-1 medications helped kids, teens and young adults with type 2 diabetes lose weight, as well as improve their blood pressure and blood sugar control. “Our results confirm that GLP-1 receptor ...
Rising costs of health benefits: Total cost per employee expected to rise 8.2% in 2027
Joseph Kra, Marsh senior partner and northeast health zone practice leader, joins 'Squawk Box' to discuss the rising costs of health benefits, impact of GLP-1s on health benefit costs, and more.
JB Pritzker Says He Used GLP-1s to Lose 80 Pounds
Gov. JB Pritzker of Illinois, widely seen as a potential presidential candidate, revealed in an interview on “CBS Mornings” that he had been on a GLP-1 regimen since 2024.
Nutrition Strategies to Improve Health With Protein, Fiber, Carbs
Following the release of a new food pyramid and dietary guidelines for Americans, nutrition expert and author of "The Whole Body Reset," Heidi Skolnick joins TODAY with what the recommendations mean for you, how to pace protein intake, how to get more fiber in your diet through foods, what people on GLP-1s should keep in mind about the new guidelines and more.
Employer healthcare expenses could spike 9.5% in 2027, pressured by GLP-1s
The benefits management company Aon said per-employee expenditures may rise about $19,000. While the broader economy is to blame, part of the rise can be attributed to the management of costly chronic conditions such as diabetes.
The weight I lost with GLP-1s came back 'with taxes' — how I finally dropped 100 lbs and kept it off
GLP-1s: the science behind today’s weight-loss drugs
The medicines reshaping obesity treatment grew out of research into how the body handles a meal. Long before weekly weight-loss injections became familiar, scientists were studying signals that travel from the intestine to the pancreas, helping it release insulin when nutrients arrive.
Serena Williams and the coming reckoning with GLP-1s and performance enhancement
GLP-1s are not prohibited; the way they work means they might never be. Anti-doping authorities are still monitoring how athletes use them.
Employers find new option for workers' GLP-1 demand
Workers want access to GLP-1s, and employers want to avoid the cost of obesity-related illness.
How ‘people power’ and business transformed medicine, but created a whole new set of risks
We’re seeing what happens when consumer demand collides with commercial interests for drugs including GLP-1s, psychedelics and testosterone. It’s a huge shift.
Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling
The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network.
Does Medicare Cover GLP-1s For Weight Loss? What To Know In 2026
Does Medicare Cover GLP-1s For Weight Loss? What To Know In 2026
What’s the true risk for eating disorders with GLP-1s?
The state of Covid-19 in 2026, a hat to treat depression, and other health news from Morning Rounds
Telemedicine company offers GLP-1s for addiction
A CDC Covid restructuring, public trust in Fauci, and more health news from Morning Rounds
Does stopping GLP-1s make you gain the weight back? What the science says
A trio of recent studies suggest that some people can keep the weight off.
GLP-1 smuggling means big business for Brazil’s black market
With 5.5% of Brazil’s population using GLP-1s, smugglers are profiting from the illegal movement and sales of medication
13 surprising ways GLP-1s may benefit the body, according to science
A condition-by-condition guide to GLP-1 drugs breaks down what’s proven, promising and still untested.
GLP-1s And Alcohol Addiction: Potential Benefits And What You Need To Know
GLP-1s And Alcohol Addiction: Potential Benefits And What You Need To Know
In 2026, Kennedy’s MAHA vision gets put to the test. Here are 3 issues to watch
In 2026, Robert F. Kennedy Jr.'s health policy changes will start playing out on GLP-1s, dietary guidelines, and rural health initiatives.
Health Watch: Watch what you eat during food illness outbreaks; GLP-1s may help with dementia
GLP-1s may help –– not harm –– male fertility
Not only are GLP-1 medications likely not harmful to male fertility, but they may help improve testosterone levels, sperm health and production, study says.
GLP-1s And Kidney Disease: Potential Benefits And What Experts Say
GLP-1s And Kidney Disease: Potential Benefits And What Experts Say
Waiting for insurance coverage for GLP-1s for weight loss? Keep waiting.
The corporations that pay for private employee health insurance are not ready to swallow the high costs of the enormously popular drugs, said the CEO of CVS Health.
GLP-1s can affect how often some people need to take time off work, study finds
An analysis of employees in Denmark finds that diabetics taking Ozempic had fewer absences from work.
GLP-1s may have a host of other health benefits. Just ask these people
Here is what scientists currently know about GLP-1s, and where hype may be getting ahead of the evidence.
Should everyone be on GLP-1s? What science actually tells us (and doesn't) about the broader health benefits
The laundry list of possible health benefits from GLP-1 drugs seems to get longer by the day, from cancer prevention to combating addiction. But while there’s no question these medications show immense promise beyond their use for diabetes and weight loss, science is still catching up.
Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50
Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for GLP-1 medications for weight loss.
Health or Hoax?
Although GLP-1s may cultivate confidence and belonging among gay and bisexual men, they can also reinforce idealized body types that can be unhealthy and socially exclusionary.
GLP-1s may increase risk of osteoporosis and gout, new research finds
A large analysis suggests the popular weight loss drugs may carry an increased risk to bone health.
Weight-loss drugs like GLP-1s are easy to buy online raising overdose and safety concerns
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded.
World Health Organization recommends GLP-1s for obesity. There's a catch.
The WHO issued guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment.
Why quitting Ozempic and GLP-1s can be bad for your heart health
People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.
How GLP-1s Are Reshaping the Business of Healthcare
John Teasley, Market Executive, Wells Fargo Healthcare Banking joins Good Day DC.
Hims & Hers Announces Strategic Shift for US Weight Loss Business
Starting with a new collaboration with Novo Nordisk, the company announced plans to align its US and global strategies with a focus on an increasing variety of FDA-approved GLP-1s Hims Hers Health, Inc. (NYSE: HIMS) today announced a collaboration with Novo Nordisk as part of a new strategy for weight loss care treatments involving GLP-1s, evolving its US offering to match the company’s approach globally. In the US, the company now plans to provide GLP-1 customers with access to a broad assortment of FDA-approved medications and offer compounded semaglutide through the platform on a limited scale. By aligning its domestic and international models in weight loss, Hims Hers will become the largest global consumer health platform for access to more affordable, approved medications. The US weight loss landscape has transformed dramatically since Hims Hers entered the market in 2023. Progress in the industry has made a broader range of FDA-approved GLP-1 treatments
People with eating disorders are taking GLP-1s and doctors are alarmed
Providers said they are encountering patients seeking treatment for anorexia, bulimia and binge eating disorder who are taking GLP-1 drugs.